Laird Norton Wetherby Wealth Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-3,570
Closed -$244K – 958
2023
Q2
$244K Buy
+3,570
New +$230K 0.01% 782
2023
Q1
– Sell
-3,840
Closed -$231K – 942
2022
Q4
$231K Sell
3,840
-3,242
-46% -$190K 0.01% 759
2022
Q3
$429K Sell
7,082
-2,000
-22% -$63.2K 0.03% 543
2022
Q2
$247K Buy
9,082
+2,500
+38% +$73.1K 0.02% 748
2022
Q1
$241K Buy
+6,582
New +$237K 0.01% 790
2021
Q4
– Sell
-3,906
Closed -$278K – 953
2021
Q3
$278K Sell
3,906
-741
-16% -$46K 0.02% 743
2021
Q2
$239K Buy
+4,647
New +$145K 0.01% 797

Other funds holding PRTA

Laird Norton Wetherby Wealth Management's PRTA Position: Q3 2023 in Review

Laird Norton Wetherby Wealth Management sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 3,570 shares — an estimated $244K sold.

Laird Norton Wetherby Wealth Management first reported a position in PRTA in Q2 2021 and held it in 7 quarters. The position peaked at $429K in Q3 2022. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

  • Laird Norton Wetherby Wealth Management reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 3,570 Prothena Corp shares in Q3 2023, an estimated $244K.
  • Laird Norton Wetherby Wealth Management first reported a position in Prothena Corp in Q2 2021 and held it in 7 quarters.
  • Laird Norton Wetherby Wealth Management's Prothena Corp position peaked at $429K in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.